HTG Molecular Diagnostics (HTGM) Reports Q1 Loss Per Share of $14.99
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HTGM Hot Sheet
Join SI Premium – FREE
HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q1 EPS of ($14.99), versus ($37.80) reported last year. Revenue for the quarter came in at $1 million, versus $827 thousand reported last year.
For earnings history and earnings-related data on HTG MOLECULAR DIAGNOSTICS, INC (HTGM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Medline Inc. (MDLN) Reports Q3 EPS of $0.44
- Seres Therapeutics (MCRB) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
